Australia's most trusted source of pharma news
Friday, 25 May 2018
Lost Your Access?
Melanoma trend outpaces PBAC
'Sweeping' guideline changes back new drugs despite lack of reimbursement.
AbbVie uses model to lure men
Instagram campaign features 'Bec Payne' but don't worry, she's not real.
Q1 PBS plunge hits top co's
Four out of five top 50 companies went backwards in Q1.
Biosim plants strike FDA issues
Mylan and Pfizer copies caught up as factories get letters.
Judgement day for Pfizer
ACCC's appeal in
case to be decided today.
GSK sucks up GP air time
Dominates respiratory sales calls but change is coming.
Reps ruled by three diseases
Half of GP visits cover just three therapy areas.
Aust pharma unlike world
Top company revenue comparison shows divergent rankings.
Biogen's new work/life initiative
Mindset program helps staffers step up at work and play.
Roche v Sandoz decision near
As listing looms, injunction could stop Sandoz's
Top brands eclipse PBS rivals
trounce competitors in top 10 brand scramble.
Pharma a 2018 'priority': ATO
With 19 cases already underway, taxman targets transfer pricing.
TGA opioid paper 'alarmist'
New proposal on restricting access prompts resistance.
BMS smooths trial access
Revamped online site helps Aussies find trials.
New HIV and migraine drugs
Dual-sponsored therapies score green lights.
Health squeezed till it hurts
Spare a thought for our public servants.
Pfizer, MSD, Novartis new drugs
Five more options for diabetes, blood cancer
Events & Conferences
© 2003 - 2018 Lush Media
Pharma in Focus
Jolly Good Design